1.
Morgensztern D, Perry MC, Govindan R. A phase II study of topotecan and docetaxel in patients with sensitive relapse small cell lung cancer. AO [Internet]. 2008 Jan. 1 [cited 2025 Feb. 26];47(1):152-3. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/25738